Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific

Journal of Infectious Diseases

Volumn 206, Issue 10, 2012, Pages 1589-1596

  Floyd, Rachel V ^a   Upton, Mathew ^b   Hultgren, Scott J ^c   Wray, Susan ^a   Burdyga, Theodor V ^a   Winstanley, Craig ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE;

ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CALCIUM SIGNALING; CONTROLLED STUDY; CYSTITIS; FEMALE; FIMBRIA; FIMH GENE; GENE DELETION; GENETIC COMPLEMENTATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; URETER DISEASE; URETER FUNCTION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

AGGLUTINATION; ANIMALS; FEMALE; FIMBRIAE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; METHYLMANNOSIDES; MUSCLE CONTRACTION; MUTATION; RATS; SACCHAROMYCES CEREVISIAE; TIME FACTORS; URETER; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84867730641     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis554     Document Type: Article

References (50)

1. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003; 17:227-41.
2. Honkinen O, Lehtonen O-P, Ruuskanen O, Huovinen P, Mertsola J. Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children. Br Med J 1999; 318:770-1.
3. Floyd RV, Borisova L, Bakran A, Hart CA, Wray S, Burdyga T. Morphology, calcium signalling and mechanical activity in human ureter. J Urol 2008; 180:398-405.
4. Grana L, Donnellan WL, Swenson O. Effects of gram-negative bacteria on ureteral structure and function. J Urol 1968; 99:539-50.
5. Teague N, Boyarsky S. Further effects of coliform bacteria on on ureteral peristalsis. J Urol 1968; 99:720.
6. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007; 9:2230-41.
7. Chen SL, Hung CS, Pinkner JS, et al. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci USA 2009; 106:22439-44.
8. Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003; 21:605-21.
9. Kau AL, Hunstad DA, Hultgren SJ. Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr Opin Microbiol 2005; 8:54-9.
10. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008; 85:11-9.
11. Waksman G, Hultgren SJ. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol 2009; 7:765-74.
12. Hung CS, Bouckaert J, Hung D, et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 2002; 44:903-15.
13. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301:105-7.
14. Yu J, Lin JH, Wu XR, Sun TT. Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 1994; 125:171-82.
15. Mulvey MA, Lopez-Boado YS, Wilson CL, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998; 282:1494-7.
16. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007; 4:e329.
17. Welch RA, Burland V, Plunkett G III, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002; 99:17020-4.
18. Brzuszkiewicz E, Bruggemann H, Liesegang H, et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006; 103:12879-84.
19. Chen SL, Hung CS, Xu J, et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci USA 2006; 103:5977-82.
20. Houdouin V, Bonacorsi S, Bidet P, Bingen-Bidois M, Barraud D, Bingen E. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 2006; 58:748-51.
21. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 2005; 151(Pt 6):2097-110.
22. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181:261-72.
23. Sabate M, Moreno E, Perez T, Andreu A, Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 2006; 12:880-6.
24. Abe CM, Salvador FA, Falsetti IN, et al. Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli. FEMS Immunol Med Microbiol 2008; 52:397-406.
25. Zhao L, Gao S, Huan H, et al. Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E. coli in a murine urinary tract infection model and a chicken challenge model. Microbiology 2009; 155(Pt 5): 1634-44.
26. Lau SH, Kaufmann ME, Livermore DM, et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008; 62:1241-4.
27. Lau SH, Reddy S, Cheesbrough J, et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008; 46:1076-80.
28. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
29. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35:316-21.
30. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53:2733-9.
31. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012; 67:346-56.
32. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008; 46:3900-5.
33. Burdyga T, Wray S. Action potential refractory period in ureter smooth muscle is set by Ca sparks and BK channels. Nature 2005; 436:559-62.
34. Floyd RV, Winstanley C, Bakran A, Wray S, Burdyga TV. Modulation of ureteric Ca signaling and contractility in humans and rats by uropathogenic E. coli. Am J Physiol Renal Physiol 2010; 298:F900-8.
35. Iguchi A, Thomson NR, Ogura Y, et al. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 2009; 191:347-54.
36. Fletcher JN, Embaye HE, Getty B, Batt RM, Hart CA, Saunders Jr. Novel invasion determinant of enteropathogenic Escherichia coli plasmid pLV501 encodes the ability to invade intestinal epithelial cells and HEp-2 cells. Infect Immun 1992; 60:2229-36.
37. Hung CS, Dodson KW, Hultgren SJ. A murine model of urinary tract infection. Nat Protoc 2009; 4:1230-43.
38. Korhonen TK. Yeast cell agglutination by purified enterobacterial pili. FEMS Micro Let 1979; 6:421-25.
39. Li B, Smith P, Horvath DJ Jr, Romesberg FE, Justice SS. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect 2010; 12:662-8.
40. Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 1995; 177:3680-6.
41. Hultgren SJ, Schwan WR, Schaeffer AJ, Duncan JL. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun 1986; 54:613-20.
42. Cusumano CK, Pinkner JS, Han Z, et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med 2011; 3:109-115.
43. Totsika M, Beatson SA, Sarkar S, et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 2011; 6:e26578.
44. Allsopp LP, Totsika M, Tree JJ, et al. UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 2010; 78:1659-69.
45. Valle J, Mabbett AN, Ulett GC, et al. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol 2008; 190:4147-61.
46. Otto G, Sandberg T, Marklund BI, Ulleryd P, Svanborg C. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis 1993; 17:448-56.
47. Johanson IM, Plos K, Marklund BI, Svanborg C. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog 1993; 15:121-9.
48. Johnson Jr. papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise. Infect Immun 1998; 66:4568-71.
49. Justice SS, Hung C, Theriot JA, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004; 101:1333-8.
50. Floyd R, Wray S. Calcium transporters and signalling in smooth muscles. Cell Calcium 2007; 42:467-76.